ATE325103T1 - Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren - Google Patents

Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren

Info

Publication number
ATE325103T1
ATE325103T1 AT02730443T AT02730443T ATE325103T1 AT E325103 T1 ATE325103 T1 AT E325103T1 AT 02730443 T AT02730443 T AT 02730443T AT 02730443 T AT02730443 T AT 02730443T AT E325103 T1 ATE325103 T1 AT E325103T1
Authority
AT
Austria
Prior art keywords
inhibitors
pyrimidine derivatives
selective cox
cox
selective
Prior art date
Application number
AT02730443T
Other languages
English (en)
Inventor
Alan Naylor
Jeremy John Payne
Neil Anthony Pegg
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE325103T1 publication Critical patent/ATE325103T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02730443T 2001-05-25 2002-05-23 Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren ATE325103T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0112802.4A GB0112802D0 (en) 2001-05-25 2001-05-25 Pyrimidine derivatives

Publications (1)

Publication Number Publication Date
ATE325103T1 true ATE325103T1 (de) 2006-06-15

Family

ID=9915322

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02730443T ATE325103T1 (de) 2001-05-25 2002-05-23 Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren
AT04077503T ATE412637T1 (de) 2001-05-25 2002-05-23 Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04077503T ATE412637T1 (de) 2001-05-25 2002-05-23 Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren

Country Status (28)

Country Link
US (2) US7026327B2 (de)
EP (2) EP1390351B1 (de)
JP (1) JP4291688B2 (de)
KR (1) KR100889427B1 (de)
CN (1) CN1255387C (de)
AR (1) AR036028A1 (de)
AT (2) ATE325103T1 (de)
AU (1) AU2002302764B2 (de)
BR (1) BR0209787A (de)
CA (1) CA2448192A1 (de)
CO (1) CO5540311A2 (de)
CZ (1) CZ20033204A3 (de)
DE (2) DE60211149T2 (de)
DK (1) DK1390351T3 (de)
ES (2) ES2316918T3 (de)
GB (1) GB0112802D0 (de)
HU (1) HUP0401280A3 (de)
IL (1) IL158799A0 (de)
MX (1) MXPA03010583A (de)
MY (1) MY130750A (de)
NO (1) NO326949B1 (de)
NZ (1) NZ529719A (de)
PL (1) PL366514A1 (de)
PT (1) PT1390351E (de)
SI (1) SI1390351T1 (de)
TW (1) TWI327140B (de)
WO (1) WO2002096885A1 (de)
ZA (1) ZA200308826B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021494D0 (en) 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
GB0112810D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112802D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
ATE325115T1 (de) 2002-08-19 2006-06-15 Glaxo Group Ltd Pyrimidinderivate als selektive cox-2-inhibitoren
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
GB0227443D0 (en) * 2002-11-25 2002-12-31 Glaxo Group Ltd Pyrimidine derivatives
EP1687001A2 (de) * 2003-11-19 2006-08-09 Glaxo Group Limited Verwendung von cyclooxygenase-2-selektiven hemmern zur behandlung von schizophrenie
JP2007511569A (ja) * 2003-11-19 2007-05-10 グラクソ　グループ　リミテッド 鬱病性障害の治療用のシクロオキシゲナーゼ−２阻害剤の使用
WO2021050700A1 (en) * 2019-09-13 2021-03-18 The Broad Institute, Inc. Cyclooxygenase-2 inhibitors and uses thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149109A (en) * 1962-02-20 1964-09-15 Searle & Co Certain 4-trifluoromethyl-2-(oxy/thio) pyrimidines
GB1121922A (en) * 1966-06-17 1968-07-31 Ici Ltd Pyrimidine derivatives
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
DE69422306T4 (de) * 1993-11-30 2000-09-07 G.D. Searle & Co., Chicago Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzündungen
PT781766E (pt) 1994-09-09 2004-07-30 Nippon Shinyaku Co Ltd Derivado heterociclico e medicamento
US5596008A (en) 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
EP0833664A1 (de) 1995-06-12 1998-04-08 G.D. SEARLE & CO. Kombination aus einem cyclooxygenase-2 inhibitor und einem leukotrien b4 rezeptorantagonisten zur behandlung von entzündungen
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US6020343A (en) * 1995-10-13 2000-02-01 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
JPH09241161A (ja) 1996-03-08 1997-09-16 Nippon Shinyaku Co Ltd 医 薬
JPH09266197A (ja) * 1996-03-28 1997-10-07 Mitsubishi Electric Corp 半導体装置およびその製造方法
IL127441A (en) 1996-07-18 2003-02-12 Merck Frosst Canada Inc Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors
DE69729946T2 (de) 1996-10-15 2005-01-20 G.D. Searle Llc Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
TW520362B (en) 1996-12-05 2003-02-11 Amgen Inc Substituted pyrimidine compounds and pharmaceutical composition comprising same
AU8181098A (en) 1997-07-03 1999-01-25 Du Pont Pharmaceuticals Company Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
DK1032575T3 (da) * 1997-09-05 2003-10-20 Glaxo Group Ltd 2,3-diaryl-pyrazol(1,5-b)pyridazinderivater, deres fremstilling og anvendelse som cyclooxygenase 2 (COX-2) inhibitor
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
DE19909541A1 (de) 1998-03-06 1999-10-14 American Cyanamid Co Herbizide 2-Aryloxy- bzw. 2-Arylthio-6-arylpyrimidine
US6306866B1 (en) * 1998-03-06 2001-10-23 American Cyanamid Company Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents
US6313072B1 (en) * 1999-02-18 2001-11-06 American Cyanamid Company Herbicidal 2-aryloxy-or 2-arylthio-6-arylpyrimidines
ATE261444T1 (de) * 1999-02-27 2004-03-15 Glaxo Group Ltd Pyrazolopyridine
GB9927844D0 (en) * 1999-11-26 2000-01-26 Glaxo Group Ltd Chemical compounds
GB9930358D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0003224D0 (en) * 2000-02-11 2000-04-05 Glaxo Group Ltd Chemical compounds
GB0021494D0 (en) 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
US6756498B2 (en) * 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
GB0112810D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112802D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112803D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
US6861249B1 (en) * 2002-04-09 2005-03-01 David Kent Microbial spray for animal waste

Also Published As

Publication number Publication date
CO5540311A2 (es) 2005-07-29
MXPA03010583A (es) 2004-03-09
JP4291688B2 (ja) 2009-07-08
PL366514A1 (en) 2005-02-07
US7026327B2 (en) 2006-04-11
SI1390351T1 (sl) 2006-10-31
KR100889427B1 (ko) 2009-03-23
CN1255387C (zh) 2006-05-10
NZ529719A (en) 2006-02-24
IL158799A0 (en) 2004-05-12
EP1493735A1 (de) 2005-01-05
GB0112802D0 (en) 2001-07-18
DE60229669D1 (de) 2008-12-11
DE60211149T2 (de) 2006-09-07
CN1537104A (zh) 2004-10-13
EP1493735B1 (de) 2008-10-29
TWI327140B (en) 2010-07-11
KR20040030629A (ko) 2004-04-09
NO20035206D0 (no) 2003-11-24
PT1390351E (pt) 2006-06-30
US20050187235A1 (en) 2005-08-25
MY130750A (en) 2007-07-31
AU2002302764B2 (en) 2005-12-01
DE60211149D1 (de) 2006-06-08
NO20035206L (no) 2003-11-24
BR0209787A (pt) 2004-06-01
CA2448192A1 (en) 2002-12-05
NO326949B1 (no) 2009-03-16
ES2262809T3 (es) 2006-12-01
WO2002096885A1 (en) 2002-12-05
ES2316918T3 (es) 2009-04-16
HUP0401280A3 (en) 2009-06-29
ATE412637T1 (de) 2008-11-15
HUP0401280A2 (hu) 2004-12-28
ZA200308826B (en) 2005-02-14
EP1390351B1 (de) 2006-05-03
JP2005511485A (ja) 2005-04-28
EP1390351A1 (de) 2004-02-25
DK1390351T3 (da) 2006-08-07
CZ20033204A3 (en) 2004-03-17
US20050032821A1 (en) 2005-02-10
AR036028A1 (es) 2004-08-04
HK1063311A1 (en) 2004-12-24

Similar Documents

Publication Publication Date Title
ATE395346T1 (de) Chinazolinderivate als tyrosinkinaseinhibitoren
ATE452891T1 (de) Pyrimidopyrimidone als kinaseinhibitoren
ATE404564T1 (de) Diazepinoindolderivate als kinaseinhibitoren
ATE419849T1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
ATE323072T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
DK3808743T3 (da) HIV-hæmmende pyrimidin-derivater
NO20033635D0 (no) Pyrimidinderivater for inhibering av celle-formering
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
ATE446093T1 (de) Substituierte chinazolin-derivate als aurora- kinase inhibitoren
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE60332396D1 (de) PYRAZOLOi3,4-B PYRIDINVERBINDUNGEN UND IHRE VERWENDUNG ALS PHOSPHODIESTERASE INHIBITOREN
ATE450528T1 (de) Chinazolinderivate als antitumormittel
DE60316581D1 (de) 6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase
DE602004025258D1 (de) Aminotriazol-verbindungen als proteinkinase-hemmer
ATE529421T1 (de) Chinolinderivate als phosphodiesterase-hemmer
EP1534268A4 (de) Tyrosin-kinase-hemmer
ATE400569T1 (de) 4-substituierte 1-aminocyclohexan-derivate zur verwendung als orl1-rezeptor- und mu-opiat- rezeptor-liganden
PT1401828E (pt) Compostos de n-formil-hidroxilamina como inibidores de pdf
ATE509011T1 (de) Pyrimidinderivate als 11beta-hsd1-inhibitoren
ATE382048T1 (de) Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen
DE602004026905D1 (de) 2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer
EE200300491A (et) 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena
DE60211149D1 (de) Pyrimidin derivate zur verwendung als selektive cox-2 inhibitoren
ATE302781T1 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
DE502004002570D1 (de) 2-substituierte pyrimidine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1390351

Country of ref document: EP